Interfering with leukemic stem cells
نویسندگان
چکیده
منابع مشابه
Mesenchymal Stem Cells Do Not Suppress Lymphoblastic Leukemic Cell Line Proliferation
Background: Several studies have demonstrated the immunosuppresive effects of mes-enchymal stem cells (MSCs) in allogeneic or mitogenic interactions. Cell-cell contact inhibition and secretion of suppressive soluble factors have been suggested in this re-gard. Objective: To investigate if adipose derived MSCs could inhibit Jurkat lym-phoblastic leukemia T cell proliferation during coculture. Me...
متن کاملLeukemic stem cells show the way.
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leukemic stem cells (LSCs), were isolated. The hematopoietic system is one of the best tissues for investigating cancer stem cells, since the developmental hierarchy of normal blood formation is well defined. Leukemia can now be viewed as aberrant hematopoietic processes initiated by rare leukemic s...
متن کاملTargeting leukemic stem cells with multifunctional bioactive polypeptide nanoparticles.
10.2217/FON.15.31 © 2015 Future Medicine Ltd RNA interference (RNAi) using synthetic small interfering RNA (siRNA) is being explored as a potential therapeutic strategy in oncology for silencing the expression of specific mRNA species that have been linked to chemotherapy resistance of cancer cells [1–9]. Systemically administered unformulated siRNA lack RNAi activity in vivo due to rapid enzym...
متن کاملEffect of transcription-factor concentrations on leukemic stem cells.
Increasing evidence suggests that leukemias are sustained by leukemic stem cells. However, the molecular pathways underlying the transformation of normal cells into leukemic stem cells are still poorly understood. The involvement of a small group of key transcription factors into this process was suggested by their frequent mutation or down-regulation in patients with acute myeloid leukemia (AM...
متن کاملCan immunotherapy specifically target acute myeloid leukemic stem cells?
Accumulating evidence supports the role of leukemic stem cells (LSCs) in the high relapse rate of acute myeloid leukemia (AML) patients. The clinical relevance of LSCs, which were originally characterized in xenograft models, has recently been confirmed by the finding that stem cell-like gene expression signatures can predict the clinical outcome of AML patients. The targeted elimination of LSC...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Medicine
سال: 2008
ISSN: 1078-8956,1546-170X
DOI: 10.1038/nm0508-494